NEWS 06 March 2019 – First targeted protein degrader hits the clinic – New therapeutics that harness cellular machinery to degrade targets are entering clinical trials, led by a PROTAC anticancer candidate developed by Arvinas.

https://www.nature.com/articles/d41573-019-00043-6

3 Comments

  1. I have read so many articles regarding the blogger lovers except this piece of writing is really a fastidious paragraph,
    keep it up.

    Like

  2. Nice blog! Is your theme custom made or did you download it from somewhere?
    A design like yours with a few simple adjustements would really make my blog stand out.
    Please let me know where you got your theme. Many thanks

    Like

Leave a Reply to Austin Cancel reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s